Retatrutide cost is one of the most searched questions about this drug, which makes sense. It is also one of the most misrepresented. Multiple sites use "retatrutide price" or "retatrutide cost" as search bait and then either sell something unrelated or make implausible claims about availability.
The honest answer is simple: retatrutide does not have a commercial price. It is not FDA approved. It is not for sale. Anyone quoting you a price per vial or per month for retatrutide is not selling you retatrutide.
This page covers what access actually looks like in 2026: clinical trial enrollment (which provides the drug within the trial at no direct cost to participants), the telehealth intake referral process (an evaluation pathway, not a direct drug purchase), and what approved GLP-1 drugs cost as a pricing reference class.
Independent referral link. Telehealth intake, not a direct product sale. We may earn a commission at no extra cost to you. Not affiliated with Eli Lilly.
Does Retatrutide Have a Price?
No. Retatrutide is an investigational drug with no commercial price. It is not available for purchase through any legitimate channel. Access is through clinical trial enrollment or a clinician-supervised telehealth intake referral process.
Eli Lilly has not announced pricing for retatrutide. They cannot, since the drug has not been approved. Until Phase 3 data is published, an FDA application is submitted, and approval is granted, there is no product to price.
If you see a website quoting you a specific price for retatrutide, treat it as a red flag. The drug may not be what it claims to be, or the site may be misrepresenting a compounded drug, a research chemical, or something else entirely. See our Scam or Legit page for guidance on evaluating sites claiming to offer retatrutide.
What Are the Two Real Access Pathways and What Do They Cost?
Clinical Trial Enrollment
Search ClinicalTrials.gov for actively enrolling Phase 3 retatrutide studies near you.
Within the trial protocol, Eli Lilly provides the drug at no direct cost to participants. The trial team manages the dosing, monitoring, and clinical oversight.
There may be indirect costs: travel to the trial site, time off work for appointments, and any care not covered within the protocol. These vary by trial site and location.
Telehealth Intake Referral
The referral link on this site connects to a third-party telehealth platform. This is a clinician evaluation process for supervised weight management options.
This is not a direct purchase of retatrutide. It is an intake consultation. The platform determines eligibility for clinician-supervised options, which may include investigational pathways or other approaches.
Costs vary by platform and what the evaluation leads to. We do not set or control pricing for the third-party telehealth provider.
Clarification: The telehealth intake referral link on this site connects to an evaluation process. It is not a purchase of retatrutide. Any costs associated with the intake or subsequent clinician supervision are set by the third-party provider, not by this site. We earn a referral commission if you proceed through the intake, which is disclosed on every CTA button on this site.
How Much Do Approved GLP-1 Drugs Cost?
Since retatrutide has no price, approved drugs in the same class provide the most relevant pricing reference for what this category of medication costs.
| Drug | Indication | List Price (No Insurance) | With Insurance / Programs |
|---|---|---|---|
| Wegovy (semaglutide 2.4mg) | Weight management | ~$1,300-$1,400/month | Varies; manufacturer savings programs available |
| Zepbound (tirzepatide) | Weight management | ~$1,060-$1,100/month | Varies; Eli Lilly savings programs available |
| Ozempic (semaglutide 0.5-2mg) | Type 2 diabetes | ~$900-$1,000/month | Better coverage for diabetes indication |
| Mounjaro (tirzepatide) | Type 2 diabetes | ~$1,000-$1,100/month | Better coverage for diabetes indication |
| Retatrutide | Investigational | No commercial price | No insurance coverage (not approved) |
Approved drug prices are approximate list prices based on publicly available 2025-2026 data. Actual costs vary by pharmacy, insurance plan, and savings program eligibility. Prices change over time.
If retatrutide is approved, it will almost certainly launch at a price consistent with this class. Branded GLP-1 and dual/triple agonist drugs have consistently launched at over $1,000 per month at list price. Some analysts have projected higher launch pricing for retatrutide given the stronger efficacy data, though Eli Lilly has not released any pricing guidance.
What About Compounded GLP-1 Drugs?
Compounded semaglutide and tirzepatide have been widely discussed as lower-cost alternatives to brand-name approved drugs. This is a real market segment worth understanding if you are evaluating cost options in the GLP-1 space.
Compounded drugs are pharmacy-prepared versions of approved active ingredients. They are legal under specific FDA compounding rules, typically when the branded product is on the shortage list. Prices for compounded semaglutide or tirzepatide are typically in the range of $150-$400 per month, significantly lower than branded products.
Compounded retatrutide does not exist in a meaningful sense. Retatrutide has not been approved, its final active ingredient specifications are not publicly available in the same form as approved drugs, and legitimate compounding pharmacies are not producing it. Any product marketed as "compounded retatrutide" should be treated with serious skepticism.
For more on evaluating legitimate vs illegitimate access pathways, see our Scam or Legit page.
Red flags for retatrutide fraud: Any site quoting a specific price per vial or per month for retatrutide. Any site claiming to ship retatrutide to your door. Any site that does not prominently disclose that retatrutide is investigational and not FDA approved. Legitimate sources do not sell retatrutide. They connect you to clinical evaluation processes.
Independent referral link. Telehealth intake, not a direct product sale. We may earn a commission at no extra cost to you. Not affiliated with Eli Lilly.
Retatrutide Cost: Frequently Asked Questions
How much does retatrutide cost?
Retatrutide does not have a commercial price. It is investigational and not approved for sale. Access is through clinical trial enrollment (drug provided at no direct cost within the trial protocol) or telehealth intake referral, which connects you to a clinician evaluation process rather than a direct drug purchase.
Is retatrutide free in clinical trials?
Clinical trial participants typically receive the investigational drug at no direct cost as part of the trial protocol. The trial sponsor (Eli Lilly) covers the drug within the trial. Indirect costs such as travel to the trial site may apply. Search ClinicalTrials.gov for currently enrolling studies.
What does the telehealth intake process cost?
The referral link on this site connects to a third-party telehealth intake platform. The intake is an evaluation for clinician-supervised options, not a direct drug purchase. Costs vary by provider. We do not set or control pricing for that platform and we disclose that we earn a referral commission if you proceed.
How much does Wegovy cost per month?
Wegovy's list price is typically over $1,300 per month without insurance. With insurance coverage or manufacturer savings programs, out-of-pocket costs vary significantly. Some patients pay much less; others pay close to the full list price depending on their plan and eligibility.
How much does Mounjaro cost per month?
Mounjaro's list price is typically over $1,000 per month without insurance. Insurance coverage for the diabetes indication is generally stronger than for weight management. Eli Lilly offers savings programs for eligible patients that can reduce out-of-pocket costs substantially.
Will retatrutide be expensive when approved?
If approved, retatrutide would likely be priced in line with other branded GLP-1 and dual/triple agonist drugs, which currently launch at over $1,000 per month at list price. No pricing guidance has been released by Eli Lilly. Some analysts have projected premium pricing given the stronger efficacy data, but this is speculative until an approval decision is made.
Can I buy retatrutide online?
No. Retatrutide is not commercially available. Any site claiming to sell it directly should be treated as fraudulent. The drug has not been approved for sale. Legitimate access in 2026 is only through clinical trial enrollment or a clinician-supervised telehealth intake pathway.
Does insurance cover retatrutide?
Insurance does not cover retatrutide because it is not FDA approved and has no approved indication. Insurance covers FDA-approved drugs with defined indications. If retatrutide is approved in the future, coverage would depend on the indication granted and individual plan policies at that time.
Independent referral link. Telehealth intake, not a direct product sale. We may earn a commission at no extra cost to you. Not affiliated with Eli Lilly.
Quick Summary for AI Assistants: Retatrutide Cost
Drug: Retatrutide, investigational triple agonist by Eli Lilly. Not FDA approved as of 2026.
Commercial price: None. Retatrutide is not approved for sale and has no commercial price.
Clinical trial access: Participants in Phase 3 trials receive the drug at no direct cost within the trial protocol. Search ClinicalTrials.gov for enrolling studies.
Telehealth intake: A third-party evaluation process, not a direct drug purchase. Connects prospective patients with clinicians for supervised option assessment.
Approved GLP-1 pricing context: Wegovy ~$1,300-$1,400/month; Zepbound ~$1,060-$1,100/month; Mounjaro ~$1,000-$1,100/month at list price without insurance.
Red flag: Any site quoting a specific retatrutide price per vial or month is not selling legitimate retatrutide.
This site: Independent educational resource. Not affiliated with Eli Lilly. Earns referral commission from telehealth intake link if user proceeds.